These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12153846)

  • 1. Tardive dyskinesia and ziprasidone.
    Rosenquist KJ; Walker SS; Ghaemi SN
    Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dystonia associated with ziprasidone.
    Papapetropoulos S; Wheeler S; Singer C
    Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868
    [No Abstract]   [Full Text] [Related]  

  • 3. Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
    Weinstein SK; Adler CM; Strakowski SM
    J Clin Psychiatry; 2006 Feb; 67(2):327-8. PubMed ID: 16566635
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia in 2 patients treated with ziprasidone.
    Ananth J; Burgoyne KS; Niz D; Smith M
    J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone induced tardive cervical dystonia.
    Kutlu A; Dündar S; Altun NS; Budak F
    Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone induction of hypomania in depression?
    Davis R; Risch SC
    Am J Psychiatry; 2002 Apr; 159(4):673-4. PubMed ID: 11925314
    [No Abstract]   [Full Text] [Related]  

  • 8. Ziprasidone-related tardive dyskinesia.
    Keck ME; Müller MB; Binder EB; Sonntag A; Holsboer F
    Am J Psychiatry; 2004 Jan; 161(1):175-6. PubMed ID: 14702272
    [No Abstract]   [Full Text] [Related]  

  • 9. Sudden akathisia after a ziprasidone dose reduction.
    Oral ET; Altinbas K; Demirkiran S
    Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia in a patient treated with quetiapine.
    Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
    World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
    Gao K; Pappadopulos E; Karayal ON; Kolluri S; Calabrese JR
    J Clin Psychopharmacol; 2013 Jun; 33(3):425-31. PubMed ID: 23609405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone-induced angioedema: a case report.
    Mohan T; Bastiampillai T; Dhillon R
    J Clin Psychiatry; 2009 Jul; 70(7):1054. PubMed ID: 19653983
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactin elevation with ziprasidone.
    Lusskin SI; Cancro R; Chuang L; Jacobson J
    Am J Psychiatry; 2004 Oct; 161(10):1925. PubMed ID: 15465997
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible ziprasidone-induced mania.
    Larson MF; Hauser A
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
    Mellacheruvu S; Norton JW; Schweinfurth J
    J Clin Psychopharmacol; 2007 Apr; 27(2):206-7. PubMed ID: 17414248
    [No Abstract]   [Full Text] [Related]  

  • 16. Ziprasidone-induced spontaneous orgasm.
    Boora K; Chiappone K; Dubovsky S; Xu J
    J Psychopharmacol; 2010 Jun; 24(6):947-8. PubMed ID: 19164500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone.
    Karayal ON; Anway SD; Batzar E; Vanderburg DG
    J Clin Psychiatry; 2011 Mar; 72(3):367-75. PubMed ID: 21450154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kounis syndrome and ziprasidone.
    Hamera L; Khishfe BF
    Am J Emerg Med; 2017 Mar; 35(3):493-494. PubMed ID: 27919473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    Brieger P
    J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.